A Hyaluronic Acid-Conjugated Gadolinium Hepatocyte-Specific T1 Contrast Agent for Liver Magnetic Resonance Imaging

Mol Imaging Biol. 2015 Aug;17(4):497-503. doi: 10.1007/s11307-014-0819-z.

Abstract

Purpose: In this study, we synthesized hyaluronic acid-conjugated gadolinium (HA-diethylene triamine pentaacetic acid (DTPA)-Gd) and evaluated as hepatocyte-specific magnetic resonance imaging (MRI) contrast agent for the diagnosis of hepatic metastasis.

Procedures: We conducted Fourier transform (FT)-IR analysis to determine the conjugation of HA and DTPA and performed cell viability assays using NIH3T3 and FL83B cell lines. We also conducted T1-weighted MRI of HA-DTPA-Gd and gadoxetic acid to compare the paramagnetic properties of both.

Results: HA-DTPA-Gd had a higher efficiency in liver MRI compared with the commercially available liver-specific contrast agent (p < 0.001). HA-DTPA-Gd, which possessed a higher T1 relaxivity, showed excellent capability for the diagnosis of hepatic metastasis through an in vivo MRI study in comparison with gadoxetic acid (p < 0.001).

Conclusion: Based on this study, we believe that HA-DTPA-Gd has promising potential for use as a contrast agent for liver MRI of hepatic metastases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Contrast Media / chemistry*
  • Contrast Media / pharmacokinetics
  • Gadolinium / chemistry*
  • Gadolinium / pharmacokinetics
  • Hepatocytes / metabolism
  • Hyaluronic Acid / chemistry*
  • Hyaluronic Acid / pharmacokinetics
  • Liver / metabolism*
  • Liver Neoplasms, Experimental / metabolism
  • Magnetic Resonance Imaging / methods*
  • Mice
  • Mice, Inbred BALB C
  • NIH 3T3 Cells

Substances

  • Contrast Media
  • Hyaluronic Acid
  • Gadolinium